PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAG9. A total of 18 filers reported holding PDL BIOPHARMA INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $19,603,000 | +26.4% | 18,585,000 | +37.3% | 0.03% | +28.0% |
| Q1 2019 | $15,511,000 | +21.9% | 13,532,000 | +8.3% | 0.02% | +8.7% |
| Q4 2018 | $12,721,000 | +32.9% | 12,500,000 | +29.5% | 0.02% | +53.3% |
| Q3 2018 | $9,571,000 | +7.4% | 9,650,000 | 0.0% | 0.02% | 0.0% |
| Q2 2018 | $8,908,000 | -12.0% | 9,650,000 | -2.5% | 0.02% | -11.8% |
| Q1 2018 | $10,127,000 | +4.7% | 9,900,000 | -1.0% | 0.02% | 0.0% |
| Q4 2017 | $9,668,000 | +22.5% | 10,000,000 | +37.9% | 0.02% | +21.4% |
| Q3 2017 | $7,893,000 | -23.5% | 7,250,000 | -36.4% | 0.01% | -26.3% |
| Q2 2017 | $10,324,000 | -26.1% | 11,408,000 | -28.7% | 0.02% | -26.9% |
| Q1 2017 | $13,976,000 | +15.2% | 16,008,000 | +6.7% | 0.03% | +4.0% |
| Q4 2016 | $12,128,000 | – | 15,008,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SMH CAPITAL ADVISORS INC | 13,002,000 | $11,937,000 | 19.35% |
| Context Capital Management, LLC | 8,175,000 | $7,546,000 | 6.49% |
| Venator Capital Management Ltd. | 2,000,000 | $1,854,000 | 1.27% |
| LINDEN ADVISORS LP | 27,867,000 | $25,654,000 | 0.79% |
| WHITEBOX ADVISORS LLC | 22,181,000 | $20,365,000 | 0.66% |
| Pinnacle Holdings, LLC | 1,640,000 | $1,503,691,000 | 0.52% |
| WOLVERINE ASSET MANAGEMENT LLC | 16,852,000 | $15,400,000 | 0.20% |
| OAKTREE CAPITAL MANAGEMENT LP | 5,060,000 | $4,670,000 | 0.06% |
| AQR Arbitrage LLC | 3,150,000 | $2,908,000 | 0.04% |
| KENNEDY CAPITAL MANAGEMENT LLC | 1,000,000 | $917,000 | 0.02% |